Medtech grants in Spain

Closed

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Closed

Funds multi-country clinical studies that generate the safety and performance data device makers need for CE marking of orphan or breakthrough medical devices.

Closed

Funds development of lab-grown human tissue models, organ-on-chip systems and AI-driven simulations that can replace animal testing in drug and medical device development.

Closed

Funds late-stage development of new diagnostic tests for vector-borne diseases such as those spread by mosquitoes and ticks.

Closed

Pays three European projects EUR 7.5 million each to develop advanced-materials sensors, from multifunctional surfaces to miniaturised wearable devices, with a guaranteed award in each of two research areas.

Closed

Funds research linking diet and nutrients to mental health, aiming at evidence and guidance for policymakers and health professionals.

Closed

Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.

Closed

Awards EUR 20,000 to a woman scientist recognised for global-health research and mentorship in sub-Saharan Africa.

Closed

Awards EUR 50,000 to a research team recognised for South-North global-health partnerships on poverty-related diseases.

Closed

Funds one project to map, replace, reduce and safely dispose of PFAS chemicals used in medicines, vaccines, devices and diagnostics.

Closed

Funds EU-wide work to pilot, roll out and evaluate lung cancer screening programmes, including AI-based detection tools.

Closed

Funds EU-wide piloting and rollout of prostate cancer screening programmes, including cross-border AI research on screening data.

Closed

Funds research proving the causal link between pollution exposure and neurological, neurodegenerative or neurodevelopmental disease, using biomarkers, imaging and long-term cohort data.

Closed

Funds research into the prevention, diagnosis and treatment of long-term health conditions that persist after a viral, bacterial, parasitic or fungal infection has cleared.

Closed

Funds pragmatic clinical trials testing tailored nutrition-based care to improve outcomes and quality of life for cancer patients aged 65 and older.

Closed

Administers research teams and institutions for PRECISEU Joint Interregional Projects on Personalised Medicine in medical technology, biotechnology, and artificial intelligence.

Closed

Funds research and digital interventions that curb the harm excessive or misguided technology use does to the mental health of children and young adults aged 15 to 24.

Closed

Funds research that updates the evidence and methods regulators use to assess medical devices, diagnostics and AI health tools, so safe innovations reach patients faster.

Closed

Funds transnational access to research infrastructure services in one of three areas — industrial biotechnology, radionuclide facilities, or climate prediction.

Closed

Funds transnational access to research infrastructure services for either epidemic-response research or paediatric clinical research, chosen as one area.

Closed

Funds cross-border teams building multimodal-data tools for personalised medicine.

Closed

Funds one project to build frameworks, guidance and recommendations that protect IP, trade secrets and regulatory data when health data is reused under the EHDS.

Closed

Funds one coordination project that maps existing cardiovascular research and builds a strategic research and innovation agenda for cutting cardiovascular disease across the EU.

Closed

Awards EUR 15,000 to a male mid-career scientist based in the EU or an associated country for global-health leadership.